Skip to Content
Browse all medications
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Advanced
Phonetic
Search:
Drugs A-Z
Complete A - Z Drug Index
Drugs by Condition
Drugs by Class
Drug Side Effects
Drug Dosage
Pregnancy Warnings
Breastfeeding Information
International Drugs
Generic Drugs
Veterinary Drugs
Natural Products
Phonetic Search
Harvard Health Topics
Medical Encyclopedia
Pill Identifier
Interactions Checker
News / Alerts
FDA Medwatch Drug Alerts
FDA Labeling Changes
Daily MedNews for Consumers
Pharmaceutical Industry News
Clinical Trial News
New Drug Approvals
New Drug Applications (Pipeline)
Get News via RSS
Get News via Twitter
Drugs.com Blog
Health Professionals
Professional Resource Center
FDA Prescribing Information
AHFS DI Monographs
A-Z Drug Facts for the Professional
Drug Interactions Checker
Patient CareNotes for the Professional
Natural Products Database
Medical Conferences
Pharmaceutical Company Directory
Medical Dictionary
Phonetic Drug Search
Community
Ask Medical Questions
Join Support Groups
Forum - Discussion Boards
Mednotes
Apps
Home
›
News
›
Pharma Industry News
› Archive
Pharmaceutical Industry News Archive
Get news
By email
or subscribe to our
News feeds
.
All News
Consumer
Pharma
New Drugs
Pipeline
Clinical Trials
August 2007
August 1
Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
Sanofi-aventis First Half 2007: Solid Results in a Difficult Context;
SurModics Acquires Brookwood Pharmaceuticals
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
Teva Reports Second Quarter 2007 Results
Southern Research Institute Spinout, Brookwood Pharmaceuticals, Acquired by SurModics for $62 Million
Cell Therapeutics, Inc. Completes Acquisition of SMi
Allergan Reports Second Quarter Operating Results
Court Takes Matter of Wyeth's Motion for Preliminary Injunction Under Advisement; Obtains Agreement from Teva and Sun to Delay Any Potential Launch of Generic Pantoprazole
Beijing Med-Pharm Announces That Alliance BMP Limited Has Received MOFCOM Approval to Acquire Interest in Guangzhou Pharmaceutical Corporation
Reorganisation of Astellas European Business Functions
Publicis Groupe Launches SSF Group
August 2
Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox
Anadys Pharmaceuticals Announces Strategic Restructuring and Reports Second Quarter 2007 Financial Results
PharmaNet Development Group Agrees to Settle 2005 Securities Class Action
New IMS Health Report Finds Generic Drugs Used More in Part D than Commercial Market
Schering-Plough Announces Dissolution of Consent Decree
August 3
BIO Applauds Court of Appeals Decision
FDA, Defense Department Share Data to Enhance Medical Product Safety Reviews
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
Novo Nordisk: Financial Statement for the Period 1 January 2007 to 30 June 2007
A Voluntary Recall of a Specific Batch of “Vesanoid Capsule,” a Treatment for Acute Promyelocytic Leukemia
Appeals Court Strikes Down D.C. Drug Price Control Law
Novo Nordisk Increased First Half-Year Operating Profit by 14% and Raises the Expectation for 2007 Operating Profit Growth to Around 10%
GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.
Healthcare Acquisition Corp. and PharmAthene Receive Stockholder Approval for Their Merger
August 6
Melior Discovery Enters New Pharmaceutical Collaboration
Santarus Reports Second Quarter 2007 Financial Results
Abbott Chief Operating Officer Richard A. Gonzalez to Retire
Novartis Concerned Indian Court Ruling Will Discourage Investments in Innovation Needed to Bring Better Medicines to Patients
Buzz in Pharma Blogs This Week Includes Pfizer HIV Marketers Getting Fired, FDA’s Hearing on Avandia, and Blogger Peter Rost is Taking Over for Journalist Jim Edwards at Brandweek NRX
August 7
King Pharmaceuticals Reports Second-Quarter 2007 Financial Results
KineMed and Merck Enter Collaboration in Atherosclerosis
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Healthcare Acquisition Corp. and PharmAthene, Inc. File Certificate of Merger to Complete Acquisition; Confirmation to Be Sought from Delaware Court of Chancery Regarding Stockholder Vote
Bayer Continues On a Path of Growth
ADHD Appears to Be Associated with Depressed Dopamine Activity in the Brain
Marketing Authorisation for the Antiretroviral Medicinal Product Viracept is Suspended
Multicultural Marketing of Health and Wellness to Women. the Trend Report Examines Ethnic & Demographic Differences in Health-care-related Opinions and Behaviors
Asia Pacific to Replace United States and Europe as Pharmaceutical Industry Powerhouse, Finds PricewaterhouseCoopers
Court Denies Terminally Ill Access to Experimental Drugs
August 8
Biovail Enters Into License and Development Agreement
Biovail Reports Second-Quarter 2007 Financial Results
AVI BioPharma Announces Refocused Clinical Development Strategy
Neuromed Announces that Merck & Co., Inc. Discontinues Development of Pain Drug Candidate, Joint Research Program Continues
Galapagos Announces Expanded Relationship with AstraZeneca
Bend Research and Pfizer Offer Proprietary Technology to Help Solve Drug-Discovery Challenges
August 9
Shareholders Approve Peptech-EvoGenix Merger
Johnson & Johnson Statement on Civil Complaint Against The American National Red Cross and Commercial Licensees
AVEO Announces Successful Completion of Discovery Agreement for Novel Cancer Drugs
IBM Introduces "ePedigree" System to Combat Drug Counterfeiting and Help Clients Comply With Regulations
WuXi PharmaTech (Cayman) Inc. Announces Pricing of Initial Public Offering on NYSE
J&J Sues Red Cross Over Use of Red Cross Emblem
FDA - MedWatch - Prilosec (omeprazole), Nexium (esomeprazole)- Early Communication About An Ongoing Safety Review
Health Canada Reviewing New Safety Information on Cardiac Events in Patients Taking Losec (omeprazole) or Nexium (esomeprazole)
ImClone Systems Appoints John H. Johnson Chief Executive Officer
August 10
Bradley Pharmaceuticals Special Committee Receives Non-binding Preliminary Bids
NICE Responds to Judicial Review Outcome
Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
This Week Pharmaceutical Blogs Discuss Departure of Managers from Pfizer’s HIV Division, Approval of Selzentry, and Johnson & Johnson Suing the Red Cross
Schering-Plough Corporation Prices Public Offering of Common Shares and 6.00% Mandatory Convertible Preferred Stock
August 13
Roche and Actavis Agree on Product Transactions
TGA: Urgent Advice Regarding Management of Patients Taking Lumiracoxib (Prexige)
Sanofi pasteur First Manufacturer to Ship Doses of Influenza Vaccine for the 2007-2008 Season
Important Dear Healthcare Provider letter about pediatric dosing
August 15
Split off of CombiMatrix Corporation Completed Today on August 15, 2007
Noven Completes Acquisition of JDS Pharmaceuticals
FDA Sends Warning Letter to Novartis Over Professional File Card
Epix Pharmaceuticals Achieves Discovery Milestone in Collaboration with GlaxoSmithKline
August 16
Amgen Restructures Due to Lower Aranesp Revenues While Continuing to Invest in Innovation and Future Growth
Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
Cell Therapeutics, Inc. (CTI) Enters Agreement to Acquire Lymphoma Drug Zevalin from Biogen Idec for Sales and Marketing in the United States
EvoGenix to Commence Second Project with GlaxoSmithKline
GlaxoSmithKline Signs Contract for Its Pandemic Flu Vaccine with UK Government
Parion Sciences and Gilead Sciences Sign Agreement to Advance Drug Candidates for Pulmonary Disease
Novartis Starts US Shipment of Fluvirin Allowing for Early Influenza Vaccination of Millions of Americans
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for Xiaflex
NEJM Direct-to-Consumer Ad Study Shows Drug Industry Incapable of Self- Regulation, Says AHF
New Clinical Trial Guidelines Reflect Northwick Park Lessons
Shanghai Century Acquisition Corporation Files Preliminary Proxy Statement
FDA Approves Updated Warfarin (Coumadin) Prescribing Information
FDA Announces Baraclude (entecavir) is Not Recommended for HIV/HBV Co-infected patients who are not also receiving HAART due to the potential for the development of HIV resistance
Spherix Shareholders Support Company's Focus on Naturlose, Biotechnology
August 17
Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
Layoffs at Amgen and Increase in DTC Advertising Are the Dominating Topics in Pharmaceutical Blogs This Week
FDA Announces Use of Codeine Products by Some Breastfeeding Mothers May Lead to Life-Threatening Side Effects in Nursing Babies
August 20
Alcon's Tender Offer Endorsed by WaveLight AG's Executive Committee and Supervisory Board
Pharming Reports Positive Results in European Placebo-Controlled Trial of Rhucin in Hereditary Angioedema
PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
MarkMonitor Brandjacking Index Exposes Online Scams That Threaten Top Pharmaceutical Brands and Hurt Consumers
The Medical House PLC: Disposal of Needle-Free Insulin Injector Business (the “Disposal”)
Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
Mackler, Fisher, and Alta Communications Acquire HMP Communications
FDA Approves ImClone Systems' New State-of-the-Art Manufacturing Facility
PCMA: Minnesota is First in the Nation to Require E-Prescribing
August 21
Medpace Strengthens Presence in Central Europe
August 22
United States District Court for the District of Arizona Grants Roche's Motion for Preliminary Injunction
Pfizer Names Frank A. D'Amelio Chief Financial Officer
Prexige 200mg and 400mg Tablets to Be Withdrawn in New Zealand
Deltagen Reports 2007 Second Quarter Financial Results and Announces a Restructuring
Roche Extends Tender Offer for Ventana
Ventana Responds to Second Extension of Roche's Unsolicited Tender Offer
NICE Appraisal of Rituximab and Adalimumab for the Treatment of Arthritis
NICE Recommends Natalizumab for the Treatment of Multiple Sclerosis
August 23
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
GlaxoSmithKline Accelerates Review of Exelixis' XL880
Abigail Alliance Will Appeal D.C. Circuit Court Decision
GPC Biotech Announces Restructuring
Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Teijin and Chugai Enter an Agreement to Co-develop Ipsen's Anti-diabetic Medicine in Japan
MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
Gene Logic Establishes Agreement with Merck Serono to Discover New Development Paths for Multiple Clinical-Stage Drug Candidates
August 24
Flemming Lindeløv is Leaving the Lundbeck Supervisory Board
Study Finds Viagra Increases Release of Key Reproductive Hormone
August 27
Gene Logic and Solvay Pharmaceuticals Enter Agreement to Discover New Development Paths for Multiple Clinical Drug Candidates
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
New 200 mg Vial for Eloxatin (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
Neurochem Announces Results from Tramiprosate (Alzhemed) North American Phase III Clinical Trial
This Week, Pharma Bloggers Discuss Pfizer’s New CFO, FDA Studying Imagery in DTC ADS, Risperdal Approved for Children and Teens, and Renewal of Chip
August 28
KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon Development
Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
Multicultural Marketing of Health and Wellness to Women. the Trend Report Examines Ethnic & Demographic Differences in Health-care-related Opinions and Behaviors
Xoma Licenses Antibody Technology to Pfizer
Practicing What They Preach: GSK Announces Employee Wellness Initiative
Statin Treatment May Curb Alzheimer's Brain Changes
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Inflazyme Pharmaceuticals Does Not Exercise Option with Helicon Therapeutics to PDE4 Inhibitor, IPL455,903, in Learning and Memory Disorders
August 29
Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents
PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
MGI Pharma Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
Merck Serono to Reconsider Development of Matuzumab in Metastatic Colorectal Cancer Patients
Immunicon Announces Laboratory Services and Assay Development Agreements with Merck Serono
National Asthma Guidelines Updated
IMS Health, Wolters Kluwer Health and Verispan Challenge State Laws Restricting Access to Critical Healthcare Information
August 30
Lilly and Takeda to Terminate Joint Development/Co-Marketing Agreement on Ruboxistaurin mesylate, An Agent for the Treatment of Diabetes Microvascular Complications
King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
GSK Supports Emphasis on Asthma Control and Use of Quick Assessment Tools in New Asthma Treatment Guidelines
Cardiome And Astellas Announce Regulatory Extension
Paion's Partner Forest Terminates Co-Development on Desmoteplase
Pfizer Proves It Can Do More with Lipitor - Protecting Vital Access to Patients at the Heart of Winning Managed Care Strategy
August 31
Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business
Boehringer Ingelheim Voluntarily Withdraws Its Clobutinol Containing Medications
AstraZeneca and Abbott Announce Selection of Next-Generation Fenofibrate (ABT-335) and Crestor Fixed-Dose Combination
Pharmaceutical Industry News Archive
2012
January
,
February
2011
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2010
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2009
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2008
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2007
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2006
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2005
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2004
January
,
February
,
March
,
April
,
May
,
July
,
August
,
September
,
October
,
November
,
December
2003
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2002
January
,
April
,
May
,
June
,
August
,
September
,
October
,
November
,
December
More News Resources
FDA Medwatch Drug Alerts
FDA Drug Safety Labeling Changes
Daily MedNews
Pharma Industry News
New Drug Approvals
New Drug Applications
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
Printable Version
Email
Recommend
Tweet
Save or Share
Search:
Sign In
or
Register
Username
Password
Forgot password?
FDA Consumer Updates
Primatene Mist With Chlorofluorocarbons No Longer Available After Dec. 31, 2011
HCG Diet Products are Illegal
Lock it Up: Medicine Safety in Your Home
Reducing Fever in Children: Safe Use of Acetaminophen
More FDA Updates...
Recently Approved
Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...
More...
Get Updates by Email
Email me:
FDA Medwatch Alerts
News Roundup
Daily
Weekly
Monthly
Email
(web2)